Evidence-biased Antidepressant Prescription

Um unseren Shop nutzen zu können, müssen Sie Javascript in Ihrem Browser aktivieren.

Dekorationsartikel gehören nicht zum Leistungsumfang.

Sprache: Englisch

123,95 €*

inkl. MwSt.

Versandkostenfrei per Post / DHL

Lieferzeit 2-3 Wochen

Sie können kein Produkt in den Warenkorb legen, da Javascript und technisch notwendige Cookies aktiviert sein müssen.

Kategorien:

Der Artikel ist nicht in deutscher Sprache verfasst.
Die Sprache der Produktbeschreibung und Details kann in Englisch angegeben sein. Sollten Sie Verständnisprobleme haben, wenden Sie sich gerne an uns.

Beschreibung

This book addresses the over-prescribing of antidepressants in people with mostly mild and subthreshold depression. It outlines the steep increase in antidepressant prescription and critically examines the current scientific evidence on the efficacy and safety of antidepressants in depression. The book is not only concerned with the conflicting views as to whether antidepressants are useful or ineffective in various forms of depression, but also aims at detailing how flaws in the conduct and reporting of antidepressant trials have led to an overestimation of benefits and underestimation of harms.

The transformation of the diagnostic concept of depression from a rare but serious disorder to an over-inclusive, highly prevalent but predominantly mild and self-limiting disorder is central to the books argument. It maintains that biological reductionism in psychiatry and pharmaceutical marketing reframed depression as a brain disorder, corroboratingthe overemphasis on drug treatment in both research and practice.

Finally, the author goes on to explore how pharmaceutical companies have distorted the scientific literature on the efficacy and safety of antidepressants and how patient advocacy groups, leading academics, and medical organisations with pervasive financial ties to the industry helped to promote systematically biased benefit-harm evaluations, affecting public attitudes towards antidepressants as well as medical education, training, and practice.

Über den Autor

Michael P. Hengartner is a senior researcher and lecturer at the Zurich University of Applied Sciences, Switzerland. He has published over 130 peer-reviewed journal articles and four book chapters. He was an expert evaluator for the European Research Council and the World Health Organization and currently is a member of the Swiss School of Public Health, the German Society for Social Psychiatry, and the European Public Health Association.

Zusammenfassung

Critiques antidepressant research and clinical practice

Posits that conflicts of interest have distorted scientific evidence

Dissects the "economies of influence" compromising the literature

Inhaltsverzeichnis

1. Introduction: How did I get here?.- 2. Antidepressants in clinical practice.- 3. Medico-cultural context.- 4. Flaws in antidepressant research.- 5. Conflicts of interest in psychiatry.- 6. Solutions for reform.

Details

Erscheinungsjahr:	2021
Fachbereich:	Angewandte Psychologie
Genre:	Psychologie
Rubrik:	Geisteswissenschaften
Medium:	Buch
Seiten:	364
Inhalt:	vii 354 S.
ISBN-13:	9783030825867
ISBN-10:	3030825868
Sprache:	Englisch
Ausstattung / Beilage:	HC runder Rücken kaschiert
Einband:	Gebunden
Autor:	Hengartner, Michael P.
Auflage:	1st ed. 2022
Hersteller:	Springer International Publishing Springer International Publishing AG
Maße:	216 x 153 x 25 mm
Von/Mit:	Michael P. Hengartner
Erscheinungsdatum:	10.12.2021
Gewicht:	0,583 kg

preigu-id: 120294306